Radiolabeled cetuximab%253A dose optimization for epidermal …
Radiolabeled cetuximab%253A dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
Article, Chapter
Authors:
B.A.W. Hoeben
Publication:
Volume:129,
Issue:4,
Page(s):870-878
Published:
2011
We were unable to find direct full text links for this item.